BIO-key cures Nasdaq listing deficiencies; all periodic reports now timely filed

BIO KEY INTERNATIONAL INC

Nasdaq notified BIO-key on June 13, 2023 that it is in compliance with Listing Rule 5250(c)(1).
Company had received deficiency notices for failure to timely file Form 10-K (year ended Dec 31, 2022) and Form 10-Q (quarter ended Mar 31, 2023).
Form 10-K was filed on June 1, 2023; Form 10-Q was filed on June 9, 2023, curing both deficiencies.
Previously closed Form 10-K matter and newly closed Form 10-Q matter remove all pending delisting risks.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.